Breaking AD diagnostic frontiers
-
Current and novel tools for AD diagnostics
-
Advances in blood-based biomarkers
-
New insights on AD diagnostics platforms
-
Bridging the gap between research and clinical practice
George Perry holds the Semmes Foundation Distinguished University Chair in Neurobiology at the University of Texas at San Antonio. Distinguished as one of the top Alzheimer’s disease researchers with over 1 000 publications, GP is one of the top 100 most-cited scientists in neuroscience and has been cited >112 000 times. He is editor-in-chief of the Journal of Alzheimer's Disease and has received numerous awards.
Jens Wiltfang is the Director of the Clinic of Psychiatry and Psychotherapy at the University Medical Center Göttingen, a Full Professor at the same institution and head of clinical research at the German Center for Neurodegenerative Diseases, site Göttingen. JW published more than 450 scientific articles, reaching almost 20 000 citations and has 7 patents registered. He has received 6 awards and/or honors.
